MacroGenics, Inc. (MGNX)
4.345
+0.10
(+2.24%)
USD |
NASDAQ |
May 18, 16:00
4.30
-0.04
(-1.04%)
After-Hours: 20:00
MacroGenics Shareholders Equity (Quarterly) : 21.20M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 1.013B |
| Gilead Sciences, Inc. | 23.52B |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Amgen, Inc. | 9.19B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 217.87M |
| Total Liabilities (Quarterly) | 196.68M |
| Debt to Equity Ratio | 4.964 |
| Current Ratio | 1.902 |
| Net Debt Paydown Yield | -7.38% |